Autoimmunity to gephyrin in Stiff-Man syndrome

Area of Science:

• Neuroimmunology
• Synaptic Biology
• Autoimmune Disorders

Background:

• Stiff-Man syndrome (SMS) is a rare central nervous system (CNS) autoimmune disorder causing chronic rigidity and spasms.
• Autoimmunity in SMS often targets synaptic antigens, frequently the GABA-synthesizing enzyme glutamic acid decarboxylase (GAD).
• A subset of SMS cases exhibit an autoimmune paraneoplastic origin, linked to underlying cancers.

Observation:

• This study identified high-titer autoantibodies targeting gephyrin in a patient presenting with SMS clinical features.
• The patient also had a diagnosed mediastinal cancer, suggesting a paraneoplastic autoimmune response.
• Gephyrin, a key protein in inhibitory synapses, is crucial for GABA(A) and glycine receptor function.

Findings:

• High-titer autoantibodies against gephyrin were detected in the patient's serum.
• The presence of these autoantibodies correlates with the clinical presentation of Stiff-Man syndrome.
• This finding establishes a novel autoimmune link between gephyrin and SMS.

Implications:

• These findings highlight gephyrin as a potential new autoantigen in Stiff-Man syndrome.
• This expands our understanding of the autoimmune targets within inhibitory synapses in neurological disorders.
• Identifying gephyrin autoantibodies may aid in diagnosing SMS, particularly paraneoplastic forms, and guide therapeutic strategies.